Sunlight and vitamin D: both good for cardiovascular health.

Fahrleitner et al.1 report that patients with severe peripheral artery disease (PAD) had a high prevalence of vitamin D deficiency. The authors should be congratulated for realizing that many of the non-specific symptoms associated with PAD and immobility, i.e., muscle pain and weakness, bone aches and pains, and fatigue are also indicative for vitamin D deficiency. They found that 71% of patients with severe PAD had serum 25-hydroxyvitamin D [25(OH)D] levels that were below 9 ng/mL. Remarkably, 13% had serum calciums below the normal range and 40% had overt secondary hyperparathyroidism. The serum calcium levels are usually normal, but can be low in severe, chronic vitamin D deficiency. The hallmark for vitamin D deficiency is the measurement of a low or undetectable level of 25(OH)D in the blood.2 Although the lower limit of the normal range was 9 ng/mL, as noted by the authors, there is strong evidence that blood levels of less than 20 ng/mL lead to secondary hyperparathyroidism.2,3 Thus, if the authors had used 20 ng/mL as their cutoff, it is likely that essentially 100% of their patients were vitamin D insufficient or deficient. The clinical signs and symptoms of vitamin D deficiency are extremely subtle or nonspecific. Vitamin D deficiency causes a decrease in the efficiency of intestinal calcium absorption, which in turn, leads to an increase in the production of parathyroid hormone (PTH). PTH stimulates the kidney to produce 1,25-dihydroxyvitamin D [1,25(OH)2D], which increases the intestinal calcium absorption and with PTH stimulates osteoclast precursors to become mature osteoclasts, which in turn mobilize calcium stores from the skeleton. The increase in osteoclastic activity can precipitate and exacerbate osteoporosis. The more subtle effect, however, is that PTH also causes phosphaturia and hypophosphatemia. As a result, the calcium x-phosphate product in the blood is inadequate for normal mineralization of the bone collagen matrix resulting in osteomalacia. In adults, it is not possible to distinguish osteoporosis and osteomalacia, either by x-ray examination or by bone densitometry. Osteoporosis, i.e., holes in the bones does not cause bone pain. In contrast, osteomalacia can cause isolated or generalized bone aches and pains. Although the mechanism for bone pain is not well understood, it is possible that the unmineralized collagen matrix becomes hydrated and expands, causing outward pressure on the periosteal covering, which is innervated by pain fibers. On physical examination the application of minimum pressure with the thumb on the sternum, anterior tibia or radius and ulna will often elicit pain and discomfort, which is a helpful diagnostic sign for osteomalacia. Vitamin D deficiency also causes muscle weakness and muscle aches and pains. Glerup et al.4 reported that 88% of Danish women of Arab decent who presented with muscle pains and weakness (symptoms similar to fibromyalgia) were severely vitamin D deficient.

[1]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[2]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[3]  M. Holick,et al.  Vitamin D insufficiency among free-living healthy young adults. , 2002, The American journal of medicine.

[4]  M. Holick Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health , 2002 .

[5]  W. Grant An ecologic study of dietary and solar ultraviolet‐B links to breast carcinoma mortality rates , 2002, Cancer.

[6]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[7]  R. Strange,et al.  Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer , 2001, The Lancet.

[8]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[9]  B. Dawson-Hughes,et al.  Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. , 2000, The Journal of clinical endocrinology and metabolism.

[10]  H. Glerup,et al.  Hypovitaminosis D Myopathy Without Biochemical Signs of Osteomalacic Bone Involvement , 2000, Calcified Tissue International.

[11]  H. Glerup,et al.  Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited , 2000, Journal of internal medicine.

[12]  B. Dawson-Hughes,et al.  Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. , 1999, Journal of the American College of Nutrition.

[13]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[14]  T. Clemens,et al.  Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. , 1999, Endocrinology.

[15]  M. Holick,et al.  Redefining vitamin D insufficiency , 1998, The Lancet.

[16]  S. Rostand Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1997, Hypertension.

[17]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[18]  G. Schwartz,et al.  Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation , 1992, Cancer.

[19]  J. Tobin,et al.  Is the Recommended Daily Allowance for Vitamin D Too Low for the Homebound Elderly? , 1991, Journal of the American Geriatrics Society.

[20]  C. Garland,et al.  SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY , 1989, The Lancet.

[21]  R. Simpson,et al.  The involvement of the endocrine system in regulating cardiovascular function: emphasis on vitamin D3. , 1989, Endocrine reviews.